FH genotype stratifies LDL-C–lowering response and improves diagnostic discrimination in severe hypercholesterolemia
Severe hypercholesterolemia encompasses a broad range of phenotypes and treatment responses. Whether lipid-lowering therapy (LLT) effectiveness differs in patients with versus without pathogenic heterozygous familial hypercholesterolemia (FH) variants is not well defined, and it is uncertain if response patterns...